Journal of Pain Research,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 473 - 487
Published: Jan. 1, 2025
Acupuncture
has
long
been
used
for
migraine
treatment
as
it
is
convenient
use
and
remarkable
efficacy.
The
acupuncture-based
comprehensive
plan
widely
recognized
prevention
treatment.
However,
the
mechanism
underlying
acupuncture
efficacy
in
not
yet
completely
understood.
Our
goal
to
systematically
analyze
evaluate
this
treatment-related
basic
research.
To
retrieve
animal
experiments
investigating
action
of
treatment,
We
conducted
a
literature
search
major
databases,
period
was
inception
each
database
April
1,
2024.
Literature
screened
data
were
extracted
independently
based
on
predefined
inclusion
exclusion
criteria.
models,
points,
methods
specified
included
studies
statistically
analyzed
summarized.
Furthermore,
potential
mechanisms
discussed.
In
total,
20
experimental
present
analysis,
all
these
rats.
order
frequency
use,
models
employed
searched
dural
stimulation
model,
nitroglycerin
cortical
spreading
depression
model.
primary
points
selected
Fengchi
(GB20)
Yanglingquan
(GB34),
electroacupuncture
most
frequently
method.
primarily
involves
regulating
descending
pain
modulatory
system
inhibiting
neurotransmitters
such
CGRP,
SP,
5-HT,
well
microglial
cell
activation.
It
also
reduces
levels
inflammatory
cytokines,
thereby
mitigating
neurogenic
inflammation
improving
central
sensitization.
exerts
its
therapeutic
effect
by
neurotransmitter
release,
responses,
modulating
analgesic
mechanisms,
suppressing
glial
further
in-depth
exploration
needed
study
migraine.
Physiological Reviews,
Journal Year:
2022,
Volume and Issue:
103(2), P. 1565 - 1644
Published: Dec. 1, 2022
Calcitonin
gene-related
peptide
(CGRP)
is
a
neuropeptide
with
diverse
physiological
functions.
Its
two
isoforms
(α
and
β)
are
widely
expressed
throughout
the
body
in
sensory
neurons
as
well
other
cell
types,
such
motor
neuroendocrine
cells.
CGRP
acts
via
at
least
G
protein-coupled
receptors
that
form
unusual
complexes
receptor
activity-modifying
proteins.
These
AMY
Nature Genetics,
Journal Year:
2023,
Volume and Issue:
55(9), P. 1471 - 1482
Published: Aug. 31, 2023
Epilepsy
is
a
highly
heritable
disorder
affecting
over
50
million
people
worldwide,
of
which
about
one-third
are
resistant
to
current
treatments.
Here
we
report
multi-ancestry
genome-wide
association
study
including
29,944
cases,
stratified
into
three
broad
categories
and
seven
subtypes
epilepsy,
52,538
controls.
We
identify
26
significant
loci,
19
specific
genetic
generalized
epilepsy
(GGE).
implicate
29
likely
causal
genes
underlying
these
loci.
SNP-based
heritability
analyses
show
that
common
variants
explain
between
39.6%
90%
risk
for
GGE
its
subtypes.
Subtype
analysis
revealed
markedly
different
architectures
focal
epilepsies.
Gene-set
signals
synaptic
processes
in
both
excitatory
inhibitory
neurons
the
brain.
Prioritized
candidate
overlap
with
monogenic
targets
antiseizure
medications.
Finally,
leverage
our
results
alternate
drugs
predicted
efficacy
if
repurposed
treatment.
The Journal of Headache and Pain,
Journal Year:
2023,
Volume and Issue:
24(1)
Published: Feb. 20, 2023
Abstract
Migraine
is
a
complex
brain
disorder
explained
by
the
interaction
of
genetic
and
environmental
factors.
In
monogenic
migraines,
including
familial
hemiplegic
migraine
with
aura
associated
hereditary
small-vessel
disorders,
identified
genes
code
for
proteins
expressed
in
neurons,
glial
cells,
or
vessels,
all
which
increase
susceptibility
to
cortical
spreading
depression.
The
study
migraines
has
shown
that
neurovascular
unit
plays
prominent
role
migraine.
Genome-wide
association
studies
have
numerous
variants
each
result
only
small
overall
risk.
more
than
180
known
belong
several
networks
“pro-migraine”
molecular
abnormalities,
are
mainly
neuronal
vascular.
Genetics
also
highlighted
importance
shared
factors
between
its
major
co-morbidities,
depression
high
blood
pressure.
Further
still
needed
map
loci
then
understand
how
these
genomic
lead
cell
phenotypes.
The Journal of Headache and Pain,
Journal Year:
2024,
Volume and Issue:
25(1)
Published: Oct. 31, 2024
Migraine
is
a
common
disabling
conditions
which,
globally,
affects
15.2%
of
the
population.
It
second
cause
health
loss
in
terms
years
lived
with
disability,
first
among
women.
Despite
being
so
common,
it
poorly
recognised
and
too
often
undertreated.
Specialty
centres
neurologists
specific
expertise
on
headache
disorders
have
knowledge
to
provide
care:
however,
those
who
do
not
regularly
treat
patients
migraine
will
benefit
from
synopsis
most
relevant
updated
information
about
this
condition.
This
paper
presents
comprehensive
view
hallmarks
migraine,
genetics
diagnostic
markers,
up
treatments
societal
impact,
reports
elements
that
identify
features.
Science,
Journal Year:
2024,
Volume and Issue:
384(6698)
Published: May 23, 2024
The
molecular
pathology
of
stress-related
disorders
remains
elusive.
Our
brain
multiregion,
multiomic
study
posttraumatic
stress
disorder
(PTSD)
and
major
depressive
(MDD)
included
the
central
nucleus
amygdala,
hippocampal
dentate
gyrus,
medial
prefrontal
cortex
(mPFC).
Genes
exons
within
mPFC
carried
most
disease
signals
replicated
across
two
independent
cohorts.
Pathways
pointed
to
immune
function,
neuronal
synaptic
regulation,
hormones.
Multiomic
factor
gene
network
analyses
provided
underlying
genomic
structure.
Single
RNA
sequencing
in
dorsolateral
PFC
revealed
dysregulated
(stress-related)
non-neuronal
cell
types.
Analyses
brain-blood
intersections
>50,000
UK
Biobank
participants
were
conducted
along
with
fine-mapping
results
PTSD
MDD
genome-wide
association
studies
distinguish
risk
from
processes.
data
suggest
shared
distinct
both
propose
potential
therapeutic
targets
biomarkers.
The Journal of Headache and Pain,
Journal Year:
2023,
Volume and Issue:
24(1)
Published: July 20, 2023
Tension-type
headache
(TTH)
and
migraine
are
two
common
primary
headaches
distinguished
by
clinical
characteristics
according
to
the
3rd
edition
of
International
Classification
Headache
Disorders.
Migraine
is
identified
specific
features
such
as
being
more
prevalent
in
females,
aggravated
physical
activity,
certain
genetic
factors,
having
photophobia,
phonophobia,
nausea,
vomiting,
or
aura,
responding
drugs.
Nonetheless,
TTH
share
some
characteristics,
onset
occurring
20
s,
triggered
psychological
factors
like
stress,
moderate
pain
severity,
mild
nausea
chronic
TTH.
Both
conditions
involve
trigeminovascular
system
their
pathophysiology.
However,
distinguishing
between
practice,
research,
epidemiological
studies
can
be
challenging,
there
a
lack
diagnostic
tests
biomarkers.
Moreover,
both
may
coexist,
further
complicating
process.
This
review
aims
explore
similarities
differences
pathophysiology,
epidemiology,
burden
disability,
comorbidities,
responses
pharmacological
non-pharmacological
treatments
migraine.
The
also
discusses
future
research
directions
address
challenges
improve
understanding
management
these
conditions.
Annals of Neurology,
Journal Year:
2023,
Volume and Issue:
94(4), P. 713 - 726
Published: July 24, 2023
The
objective
of
this
study
was
to
aggregate
data
for
the
first
genomewide
association
meta-analysis
cluster
headache,
identify
genetic
risk
variants,
and
gain
biological
insights.